Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors
- 13 February 2007
- journal article
- Published by Springer Nature in International Journal of Obesity
- Vol. 31 (6), 927-932
- https://doi.org/10.1038/sj.ijo.0803543
Abstract
Objective: Subjects: Measurements: Results: Conclusion:Keywords
This publication has 31 references indexed in Scilit:
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Standards of Medical Care in DiabetesDiabetes Care, 2005
- British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summaryBMJ, 2004
- High Expression of Complement Components in Omental Adipose Tissue in Obese MenObesity Research, 2003
- Plasma Acylation Stimulating Protein Concentration and Subcutaneous Adipose Tissue C3 mRNA Expression in Nondiabetic and Type 2 Diabetic MenArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged menEuropean Heart Journal, 2000
- Consenso SEEDO'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéuticaMedicina Clinica, 2000
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Adipose tissue as an endocrine and paracrine organInternational Journal of Obesity, 1998
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985